Submitted by Anonymous (not verified) on 6 February 2026 - 14:48
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 16, Status: Authorised